|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.130 CNY | +0.39% |
|
+2.60% | +0.20% |
| 02-13 | Jointown Pharmaceutical Says China Universal Healthcare REIT Raises 1.16 Billion Yuan From Offering | MT |
| 12-25 | Jiuzhoutong Pharmaceutical Receives CSRC Approval for REITs | MT |
| Capitalization | 25.2B 3.48B 3.2B 3.08B 2.7B 5.01B 303B 5.51B 35.31B 13.38B 128B 13.05B 12.79B 516B | P/E ratio 2024 * |
11.4x | P/E ratio 2025 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise value | 24.29B 3.36B 3.08B 2.97B 2.6B 4.83B 292B 5.31B 34.03B 12.9B 123B 12.58B 12.32B 498B | EV / Sales 2024 * |
0.16x | EV / Sales 2025 * | 0.12x |
| Free-Float |
41.34% | Yield 2024 * |
5.05% | Yield 2025 * | 5.74% |
More valuation ratios
* Estimated data
More news
| 1 day | +0.39% | ||
| 1 week | +2.60% | ||
| Current month | +3.85% | ||
| 1 month | +0.20% | ||
| 3 months | -6.22% | ||
| 6 months | +16.06% | ||
| Current year | +0.20% |
1 week
4.98
5.13
1 month
4.94
5.13
Current year
4.74
5.13
1 year
4.35
5.13
3 years
3.969
5.13
5 years
3.969
5.13
10 years
3.969
5.13
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 39 | 2022-04-22 |
Xi Zhang
IRC | Investor Relations Contact | - | 2022-04-22 |
Zhi Feng Liu
IRC | Investor Relations Contact | 42 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 65 | 2008-11-15 |
Deng Pan Liu
BRD | Director/Board Member | 47 | 2020-11-04 |
Yi Hua Gong
BRD | Director/Board Member | 47 | 2012-06-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.39% | +2.60% | -16.44% | +3.72% | 3.48B | ||
| +1.05% | +0.96% | +22.87% | +128.34% | 81.52B | ||
| +1.37% | +1.19% | +16.44% | +143.30% | 30.92B | ||
| +2.86% | -0.35% | - | - | 20.99B | ||
| +1.47% | +2.48% | +10.61% | +0.47% | 8.89B | ||
| +1.72% | +4.35% | +6.39% | +3.71% | 8.58B | ||
| +0.52% | -0.41% | -8.02% | +10.92% | 7.83B | ||
| +0.10% | -0.15% | +19.98% | - | 5.47B | ||
| -7.07% | -5.37% | +5.44% | +17.16% | 4.36B | ||
| +0.97% | -0.21% | +1.48% | -0.89% | 4.21B | ||
| Average | +0.34% | +0.20% | +6.53% | +38.34% | 17.63B | |
| Weighted average by Cap. | +1.11% | +0.73% | +16.37% | +100.80% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 155B 21.39B 19.67B 18.93B 16.56B 30.8B 1,860B 33.88B 217B 82.25B 785B 80.2B 78.58B 3,173B | 167B 23.01B 21.15B 20.36B 17.82B 33.12B 2,001B 36.44B 233B 88.47B 844B 86.26B 84.52B 3,413B |
| Net income | 2.37B 327M 301M 289M 253M 471M 28.44B 518M 3.32B 1.26B 11.99B 1.23B 1.2B 48.51B | 2.71B 375M 344M 331M 290M 539M 32.58B 593M 3.8B 1.44B 13.74B 1.4B 1.38B 55.56B |
| Net Debt | -912M -126M -116M -111M -97.5M -181M -10.95B -199M -1.28B -484M -4.62B -472M -463M -18.68B | -4.4B -608M -559M -538M -471M -876M -52.9B -963M -6.17B -2.34B -22.31B -2.28B -2.23B -90.23B |
More financial data
* Estimated data
Employees
30,100
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-03-14 | 5.130 ¥ | +0.39% | 46,554,550 |
| 25-03-13 | 5.110 ¥ | +1.59% | 53,869,920 |
| 25-03-12 | 5.030 ¥ | -0.40% | 15,059,190 |
| 25-03-11 | 5.050 ¥ | -0.20% | 18,592,150 |
| 25-03-10 | 5.060 ¥ | +1.20% | 28,467,670 |
End-of-day quote Shanghai S.E., March 13, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
5.130CNY
Average target price
6.380CNY
Spread / Average Target
+24.37%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600998 Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition